Dow Jones
39.110,28 -59,24 (-0,15%) Nasdaq
17.901,57 +22,27 (+0,12%) Nikkei 225
40.074,69 +443,63 (+1,12%) EUR/USD
1,0735 -0,0007 (-0,06%) Bitcoin EUR
57.532,39 -1.311,50 (-2,23%) CMC Crypto 200
1.308,29 -36,22 (-2,69%)
Laboratory Corp of America Holdings (LAB.DU)
| Chiusura precedente | 190,00 |
| Aperto | 193,00 |
| Denaro | 0,00 x 0 |
| Domanda | 0,00 x 0 |
| Min-Max giorno | 190,00 - 193,00 |
| Intervallo di 52 settimane | 169,16 - 210,00 |
| Volume | |
| Media Volume | 0 |
| Capitalizzazione | N/D |
| Beta (mensile su 5 anni) | N/D |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | N/D |
| Prossima data utili | 25 lug 2024 - 29 lug 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireSingular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors
SAN DIEGO, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the appointment of Marcia Eisenberg, Ph.D., to the Company’s Board of Directors. Dr. Eisenberg currently serves as Senior Vice President and Enterprise Chief Scientific Officer at Labcorp (NYSE: LH) and brings more than 30 years of experience with molecular geneti
GlobeNewswireEnzo Biochem Completes Sale of Clinical Laboratory to Labcorp
Significant value unlocked for Enzo shareholders with continued focus on life sciences. FARMINGDALE, NY, July 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has closed a transaction to sell certain assets of Enzo’s Clinical laboratory division (Enzo Clinical Labs) to Laboratory Corporation of America Holdings (Labcorp) (NYSE:LH) pursuant to an Asset Purchase Agreement dated March 16, 2023, as amended July 3, 2023. ASSET SALE Enzo Biochem has completed the prev
